CLO26-123: Genomic Adjusted Radiation Dose (GARD) Predicts Optimal Radiation Dose for Overall Survival in Triple-Negative Breast Cancer
Journal of the National Comprehensive Cancer Network · 31.03.2026 · 24 (3.5)
DOI: 10.6004/jnccn.2025.7252 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the National Comprehensive Cancer Network, erschienen am 31.03.2026. Verfasst von Shivani Nellore und 6 weiteren Autor:innen. Beteiligte Einrichtung: 1Case Western Reserve University, Cleveland, OH.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- 1Case Western Reserve University, Cleveland, OH.
- 2Penn Medicine, Philadelphia, PA.
- 3Moffitt Cancer Center, Tampa, FL.
Zitieren
APA
Nellore, S., Ho, E., Joshi, N., Chen, P., Nowacki, A., Torres-Roca, J., & Scott, J. (2026). CLO26-123: Genomic Adjusted Radiation Dose (GARD) Predicts Optimal Radiation Dose for Overall Survival in Triple-Negative Breast Cancer. Journal of the National Comprehensive Cancer Network, 24(3.5). https://doi.org/10.6004/jnccn.2025.7252
Vancouver
Nellore S, Ho E, Joshi N, Chen P, Nowacki A, Torres-Roca J, et al. CLO26-123: Genomic Adjusted Radiation Dose (GARD) Predicts Optimal Radiation Dose for Overall Survival in Triple-Negative Breast Cancer. Journal of the National Comprehensive Cancer Network. 2026;24(3.5). doi:10.6004/jnccn.2025.7252
BibTeX
@article{Nellore2026,
author = {Nellore, Shivani and Ho, Emily and Joshi, Nikhil and Chen, Peng and Nowacki, Amy and Torres-Roca, Javier and Scott, Jacob},
title = {CLO26-123: Genomic Adjusted Radiation Dose (GARD) Predicts Optimal Radiation Dose for Overall Survival in Triple-Negative Breast Cancer},
journal = {Journal of the National Comprehensive Cancer Network},
year = {2026},
volume = {24},
number = {3.5},
doi = {10.6004/jnccn.2025.7252}
}
EUVIMED